-
1
-
-
2642709177
-
HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
-
Mar 26;
-
Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al; HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998 Mar 26;338(13):853-60.
-
(1998)
N Engl J Med
, vol.338
, Issue.13
, pp. 853-860
-
-
Palella Jr, F.J.1
Delaney, K.M.2
Moorman, A.C.3
Loveless, M.O.4
Fuhrer, J.5
Satten, G.A.6
-
2
-
-
0038162585
-
EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: An observational study
-
Jul 5;
-
Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al; EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003 Jul 5;362(9377):22-9.
-
(2003)
Lancet
, vol.362
, Issue.9377
, pp. 22-29
-
-
Mocroft, A.1
Ledergerber, B.2
Katlama, C.3
Kirk, O.4
Reiss, P.5
d'Arminio Monforte, A.6
-
3
-
-
34248400730
-
UNAIDS. Progress on global access to HIV antiretroviral therapy
-
World Health Organization;, Geneva: WHO;
-
World Health Organization; UNAIDS. Progress on global access to HIV antiretroviral therapy. A report on "3 by 5" and beyond. Geneva: WHO; 2006.
-
(2006)
A report on 3 by 5
-
-
-
4
-
-
62649086445
-
World Summit Outcome
-
United Nations [homepage on the Internet, 24 October, cited 2007 Dec 17, Available from
-
United Nations [homepage on the Internet]. 2005 World Summit Outcome. General Assembly 60/1.24 October 2005 [cited 2007 Dec 17]. Available from: http://unpan1.un.org/intradoc/groups/public/documents/UN/UN-PAN021752.pdf.
-
(2005)
General Assembly
, vol.60
, Issue.1
-
-
-
5
-
-
48749127377
-
UNAIDS; UNICEF. Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector
-
World Health Organization;, Geneva: WHO;
-
World Health Organization; UNAIDS; UNICEF. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2008. Geneva: WHO; 2008.
-
(2008)
Progress report 2008
-
-
-
6
-
-
0037055025
-
-
Yeni Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society -USA Panel. JAMA. 2002 Jul 10;288(2):222-35. Erratum in: JAMA. 2003 Jan-Feb;11(1):32.
-
Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society -USA Panel. JAMA. 2002 Jul 10;288(2):222-35. Erratum in: JAMA. 2003 Jan-Feb;11(1):32.
-
-
-
-
7
-
-
17344387406
-
European guidelines for the clinical management and treatment of HIV infected adults in Europe
-
The EACS Euroguidelines Group, Jun;
-
The EACS Euroguidelines Group. European guidelines for the clinical management and treatment of HIV infected adults in Europe. AIDS. 2003 Jun;17 Suppl 2:83-26.
-
(2003)
AIDS
, vol.17
, Issue.SUPPL. 2
, pp. 83-26
-
-
-
11
-
-
13844312888
-
German-Austrian recommendations for the antiretroviral therapy of HIV-infections (status May 2004)
-
Nov 29;
-
Salzberger B, Marcus U, Vielhaber B, Arasteh K, Golz J, Brockmeyer NH, et al. German-Austrian recommendations for the antiretroviral therapy of HIV-infections (status May 2004). Eur J Med Res. 2004 Nov 29;9(11):491-504.
-
(2004)
Eur J Med Res
, vol.9
, Issue.11
, pp. 491-504
-
-
Salzberger, B.1
Marcus, U.2
Vielhaber, B.3
Arasteh, K.4
Golz, J.5
Brockmeyer, N.H.6
-
12
-
-
0037072066
-
-
Egger M, May M, Chêne G, Phillips AN, Ledergerber B, Dabis F, et al; ART Cohort Collaboration. Prognosis of HIV-1 -infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002 Jul 13;360(9327): 119-29. Erratum in: Lancet 2002 Oct 12;360(9340):1178.
-
Egger M, May M, Chêne G, Phillips AN, Ledergerber B, Dabis F, et al; ART Cohort Collaboration. Prognosis of HIV-1 -infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002 Jul 13;360(9327): 119-29. Erratum in: Lancet 2002 Oct 12;360(9340):1178.
-
-
-
-
13
-
-
0035824773
-
EuroSIDA Study Group. Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients
-
Dec 7;
-
Phillips AN, Pradier C, Lazzarin A, Clotet B, Goebel FD, Hermans P, et al; EuroSIDA Study Group. Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients. AIDS. 2001 Dec 7; 15(18):2385-95.
-
(2001)
AIDS
, vol.15
, Issue.18
, pp. 2385-2395
-
-
Phillips, A.N.1
Pradier, C.2
Lazzarin, A.3
Clotet, B.4
Goebel, F.D.5
Hermans, P.6
-
14
-
-
0348147558
-
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: Longer follow-up of an observational cohort study
-
Dec 1;
-
Sterling TR, Chaisson RE, Keruly J, Moore RD. Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study. J Infect Dis. 2003 Dec 1;188(11):1659-65.
-
(2003)
J Infect Dis
, vol.188
, Issue.11
, pp. 1659-1665
-
-
Sterling, T.R.1
Chaisson, R.E.2
Keruly, J.3
Moore, R.D.4
-
15
-
-
0037024757
-
Swiss HIV Cohort Study. Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count >350 x 10(6) /1
-
Jul 5;
-
Opravil M, Ledergerber B, Furrer H, Hirschel B, Imhof A, Gallant S, et al; Swiss HIV Cohort Study. Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count >350 x 10(6) /1. AIDS. 2002 Jul 5;16(10):1371-81.
-
(2002)
AIDS
, vol.16
, Issue.10
, pp. 1371-1381
-
-
Opravil, M.1
Ledergerber, B.2
Furrer, H.3
Hirschel, B.4
Imhof, A.5
Gallant, S.6
-
16
-
-
62649090047
-
ATHENA Cohort Study Group. Predictors of changes in CD4 cell count seven years after starting HAART
-
abstract 530
-
Gras L, van Sighem A, Fraser C, Griffin J, Lange J, Miedema F, et al; ATHENA Cohort Study Group. Predictors of changes in CD4 cell count seven years after starting HAART. In: 13th Annual Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5-8; Denver, USA. Alexandria: CROI; 2006. abstract 530.
-
(2006)
13th Annual Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5-8; Denver, USA. Alexandria: CROI
-
-
Gras, L.1
van Sighem, A.2
Fraser, C.3
Griffin, J.4
Lange, J.5
Miedema, F.6
-
17
-
-
0038662719
-
HIV Outpatient Study Investigators. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata
-
Apr 15;
-
Palella FJ Jr, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Greenberg AE, et al; HIV Outpatient Study Investigators. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003 Apr 15;138(8):620-6.
-
(2003)
Ann Intern Med
, vol.138
, Issue.8
, pp. 620-626
-
-
Palella Jr, F.J.1
Deloria-Knoll, M.2
Chmiel, J.S.3
Moorman, A.C.4
Wood, K.C.5
Greenberg, A.E.6
-
19
-
-
62649132737
-
Analysis of resistance associated-mutations in patients infected with HIV-1 of subtype B and non-B from Chile
-
In The, Mar 29-31; Monte Carlo. Abstract 27
-
Rios M, Vazquez de Parga E, Perez-Alverez L, et al. Analysis of resistance associated-mutations in patients infected with HIV-1 of subtype B and non-B from Chile. In The proceedings of 4th European HIV Drug Resistance Workshop; 2006 Mar 29-31; Monte Carlo. Abstract 27.
-
(2006)
proceedings of 4th European HIV Drug Resistance Workshop
-
-
Rios, M.1
Vazquez de Parga, E.2
Perez-Alverez, L.3
-
20
-
-
32044465983
-
Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients
-
Jan;
-
Agwale SM, Zeh C, Paxinos E, Odama L, Pienazek D, Wambebe C, et al. Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naive Nigerian patients. AIDS Res Hum Retroviruses. 2006 Jan;22(1):22-6.
-
(2006)
AIDS Res Hum Retroviruses
, vol.22
, Issue.1
, pp. 22-26
-
-
Agwale, S.M.1
Zeh, C.2
Paxinos, E.3
Odama, L.4
Pienazek, D.5
Wambebe, C.6
-
21
-
-
33244493140
-
Low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia
-
Feb 1;
-
Tee KK, Kamarulzaman A, Ng KP. Low prevalence of genotypic drug resistance mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses. 2006 Feb 1;22(2):121-4.
-
(2006)
AIDS Res Hum Retroviruses
, vol.22
, Issue.2
, pp. 121-124
-
-
Tee, K.K.1
Kamarulzaman, A.2
Ng, K.P.3
-
22
-
-
33747771765
-
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon
-
Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, Laurent C, et al. HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon. Antivir Ther. 2006;11(5):575-9.
-
(2006)
Antivir Ther
, vol.11
, Issue.5
, pp. 575-579
-
-
Vergne, L.1
Diagbouga, S.2
Kouanfack, C.3
Aghokeng, A.4
Butel, C.5
Laurent, C.6
-
23
-
-
32344441696
-
Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil
-
Mar;
-
Rodrigues R, Scherer LC, Oliveira CM, Franco HM, Sperhacke RD, Ferreira JL, et al. Low prevalence of primary antiretroviral resistance mutations and predominance of HIV-1 clade C at polymerase gene in newly diagnosed individuals from south Brazil. Virus Res. 2006 Mar;116(1-2):201-7.
-
(2006)
Virus Res
, vol.116
, Issue.1-2
, pp. 201-207
-
-
Rodrigues, R.1
Scherer, L.C.2
Oliveira, C.M.3
Franco, H.M.4
Sperhacke, R.D.5
Ferreira, J.L.6
-
24
-
-
33745900537
-
Linking HIV and antiretroviral drug resistance surveillance in Peru: A model for a third-generation HIV sentinel surveillance
-
Aug 1;
-
Lama JR, Sanchez J, Suarez L, Caballero P, Laguna A, Sanchez JL, et al. Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance. J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):501-5.
-
(2006)
J Acquir Immune Defic Syndr
, vol.42
, Issue.4
, pp. 501-505
-
-
Lama, J.R.1
Sanchez, J.2
Suarez, L.3
Caballero, P.4
Laguna, A.5
Sanchez, J.L.6
-
25
-
-
75749150759
-
Low prevalence of transmitted HIV-1 drug resistance in newly diagnosed HIV-1 patients in Denmark from 2000-2004
-
In The, Mar 29-31; Monte Carlo. Abstract 22
-
Jørgensen LB, Gerstoft J, Mathiasen L, et al. Low prevalence of transmitted HIV-1 drug resistance in newly diagnosed HIV-1 patients in Denmark from 2000-2004. In The Proceedings of 4th European HIV Drug Resistance Workshop; 2006 Mar 29-31; Monte Carlo. Abstract 22.
-
(2006)
Proceedings of 4th European HIV Drug Resistance Workshop
-
-
Jørgensen, L.B.1
Gerstoft, J.2
Mathiasen, L.3
-
26
-
-
33845920015
-
Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individuals
-
Jan 11;
-
Fox J, Hill S, Kaye S, Dustan S, McClure M, Fidler S, et al. Prevalence of primary genotypic resistance in a UK centre: comparison of primary HIV-1 and newly diagnosed treatment-naive individuals. AIDS. 2007 Jan 11;21(2):237-9.
-
(2007)
AIDS
, vol.21
, Issue.2
, pp. 237-239
-
-
Fox, J.1
Hill, S.2
Kaye, S.3
Dustan, S.4
McClure, M.5
Fidler, S.6
-
28
-
-
34248222670
-
Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection
-
Mar;
-
Booth CL, Garcia-Diaz AM, Youle M, Johnson MA, Phillips A, Geretti AM. Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection. J Antimicrob Chemother. 2007 Mar;59(3):517-24.
-
(2007)
J Antimicrob Chemother
, vol.59
, Issue.3
, pp. 517-524
-
-
Booth, C.L.1
Garcia-Diaz, A.M.2
Youle, M.3
Johnson, M.A.4
Phillips, A.5
Geretti, A.M.6
-
29
-
-
33847388271
-
Transmission of HIV-1 drug resistance in Switzerland: A 10-year molecular epidemiology survey
-
Yerly S, von Wyl V, Boni J, et al. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. Antivir Ther. 2006;11(5):S118.
-
(2006)
Antivir Ther
, vol.11
, Issue.5
-
-
Yerly, S.1
von Wyl, V.2
Boni, J.3
-
30
-
-
62649091605
-
-
Routy JP, de Edwardes D, Rouleau D, et al. Influence of patient characteristics, year of infection, CD4 cell count and viral load on the presence of primary HIV-1 drug resistance in recently infected patients. Antivir Ther. 2005;10Suppl 1:S133.
-
Routy JP, de Edwardes D, Rouleau D, et al. Influence of patient characteristics, year of infection, CD4 cell count and viral load on the presence of primary HIV-1 drug resistance in recently infected patients. Antivir Ther. 2005;10Suppl 1:S133.
-
-
-
-
31
-
-
33750530598
-
Reduced levels of primary resistance to nRTIs in San Francisco is discernable using two independent sentinel populations
-
Truong HM, Klausner JD, Hecht FM, et al. Reduced levels of primary resistance to nRTIs in San Francisco is discernable using two independent sentinel populations. Antivir Ther. 2006;11(5):S115.
-
(2006)
Antivir Ther
, vol.11
, Issue.5
-
-
Truong, H.M.1
Klausner, J.D.2
Hecht, F.M.3
-
32
-
-
33745436260
-
A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: Results from the Canadian HIV strain and drug resistance surveillance program
-
May;
-
Jayaraman GC, Archibald CP, Kim J, Rekart ML, Singh AE, Harmen S, et al. A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program. J Acquir Immune Defic Syndr. 2006 May;42(1):86-90.
-
(2006)
J Acquir Immune Defic Syndr
, vol.42
, Issue.1
, pp. 86-90
-
-
Jayaraman, G.C.1
Archibald, C.P.2
Kim, J.3
Rekart, M.L.4
Singh, A.E.5
Harmen, S.6
-
33
-
-
33847395651
-
Transmission of drug-resistance in Europe is characterized by single mutations and revenants
-
Wensing AMJ, Vercauteren J, van de Vijver DA, et al. Transmission of drug-resistance in Europe is characterized by single mutations and revenants. Antivir Ther. 2006; 11(5):S111.
-
(2006)
Antivir Ther
, vol.11
, Issue.5
-
-
Wensing, A.M.J.1
Vercauteren, J.2
van de Vijver, D.A.3
-
34
-
-
23044496716
-
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: A prospective cohort study
-
Jul 30-Aug 5;
-
Sterne JA, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005 Jul 30-Aug 5;366(9483):378-84.
-
(2005)
Lancet
, vol.366
, Issue.9483
, pp. 378-384
-
-
Sterne, J.A.1
Hernán, M.A.2
Ledergerber, B.3
Tilling, K.4
Weber, R.5
Sendi, P.6
-
35
-
-
62649168537
-
-
Weber R, Friis-Mø11er N, Sabin C, et al. HIV and non-HIV-related deaths and their relationship to immunodeficiency: In The proceedings of 12th Conference on Retroviruses and Opportunistic Infections; 2005 Feb 22-25; Boston. Abstract 595.
-
Weber R, Friis-Mø11er N, Sabin C, et al. HIV and non-HIV-related deaths and their relationship to immunodeficiency: In The proceedings of 12th Conference on Retroviruses and Opportunistic Infections; 2005 Feb 22-25; Boston. Abstract 595.
-
-
-
-
36
-
-
0036788675
-
Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco 1994-1998
-
Oct 1;
-
Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco 1994-1998. J Infect Dis. 2002 Oct 1;186(7):1023-7.
-
(2002)
J Infect Dis
, vol.186
, Issue.7
, pp. 1023-1027
-
-
Louie, J.K.1
Hsu, L.C.2
Osmond, D.H.3
Katz, M.H.4
Schwarcz, S.K.5
-
37
-
-
33645277852
-
Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras
-
Feb 1;
-
Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200.
-
(2006)
J Acquir Immune Defic Syndr
, vol.41
, Issue.2
, pp. 194-200
-
-
Crum, N.F.1
Riffenburgh, R.H.2
Wegner, S.3
Agan, B.K.4
Tasker, S.A.5
Spooner, K.M.6
-
38
-
-
3042536169
-
EuroSIDA study group. Hepatitis B and hepatitis C in the EuroSIDA cohort: Prevalence and effect on mortality, AIDS progression and response to HAART
-
In The, Feb 8-11; San Francisco. Abstract 799
-
Rockstroh J, Konopnicki D, Soriano V, Kirk O, Antunes F, Knysz B, et al; EuroSIDA study group. Hepatitis B and hepatitis C in the EuroSIDA cohort: prevalence and effect on mortality, AIDS progression and response to HAART. In The proceedings of 11th Conference on Retroviruses and Opportunistic Infections; 2004 Feb 8-11; San Francisco. Abstract 799.
-
(2004)
proceedings of 11th Conference on Retroviruses and Opportunistic Infections
-
-
Rockstroh, J.1
Konopnicki, D.2
Soriano, V.3
Kirk, O.4
Antunes, F.5
Knysz, B.6
-
39
-
-
27944467897
-
EuroSIDA Study Group. Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
-
Dec 2;
-
Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, et al; EuroSIDA Study Group. Is there evidence for an increase in the death rate from liver-related disease in patients with HIV? AIDS. 2005 Dec 2;19(18):2117-25.
-
(2005)
AIDS
, vol.19
, Issue.18
, pp. 2117-2125
-
-
Mocroft, A.1
Soriano, V.2
Rockstroh, J.3
Reiss, P.4
Kirk, O.5
de Wit, S.6
|